Fresenius Medical Care Holdings, Inc. has recalled 3,651,468 containers of 0.9% Sodium Chloride Injection, USP, in flexible plastic containers. This prescription medication, which is used for intravenous infusion or wound cleansing, is being recalled because the sterility of the product cannot be guaranteed. The recall affects over 150 different lot numbers with expiration dates ranging from November 2025 to March 2026.
A lack of sterility assurance in an injectable drug poses a significant risk of infection if the product is contaminated with bacteria or other microorganisms. This is particularly dangerous for vulnerable patients or those receiving the medication directly into their bloodstream.
Recall #: D-0490-2025; Quantity: 3,651,468 containers
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.